|
|
|
|
| | | | USD | EUR | GBP | JPY | 83.34 | 89.43 | 104.26 | 0.53 |
| | | | AED | AUD | CHF | CAD | 17.54 | 49.53 | 64.49 | 50.06 |
| | | | HKD | SAR | SGD | ZAR | 8.28 | 17.22 | 47.46 | 4.57 |
|
|
|
|
|
|
|
|
|
|
|
Industry :
|
Hospital & Healthcare Services
|
|
|
|
|
|
|
|
|
|
52-Week-High (Rs.)
|
3660.00
|
|
|
52-Week-Low (Rs.)
|
1150.00
|
|
|
|
|
* BSE PRICES
|
|
|
|
|
Particulars | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Operational & Financial Ratios | | | | | | Earnings Per Share (Rs) | 78.55 | 51.28 | -3.06 | 29.11 | 25.35 | CEPS(Rs) | 121.49 | 94.66 | 37.58 | 74.29 | 48.57 | DPS(Rs) | 3.00 | 3.00 | 0.00 | 0.00 | 1.50 | Book NAV/Share(Rs) | 241.15 | 166.32 | 116.30 | 119.36 | 97.00 | Tax Rate(%) | 25.26 | 25.41 | 125.09 | 31.38 | 31.62 | Margin Ratios | | | | | | Core EBITDA Margin(%) | 28.21 | 29.15 | 21.35 | 26.78 | 17.63 | EBIT Margin(%) | 21.44 | 19.64 | 9.08 | 16.21 | 12.37 | Pre Tax Margin(%) | 18.44 | 16.06 | 4.10 | 11.33 | 10.25 | PAT Margin (%) | 13.78 | 11.98 | -1.03 | 7.78 | 7.01 | Cash Profit Margin (%) | 21.31 | 22.11 | 12.63 | 19.85 | 13.42 | Performance Ratios | | | | | | ROA(%) | 9.78 | 9.63 | -0.86 | 9.55 | 11.01 | ROE(%) | 38.56 | 36.29 | -2.60 | 26.91 | 29.55 | ROCE(%) | 42.98 | 42.40 | 16.92 | 39.87 | 34.30 | Asset Turnover(x) | 0.71 | 0.80 | 0.84 | 1.23 | 1.57 | Sales/Fixed Asset(x) | 0.81 | 0.89 | 0.95 | 1.63 | 2.68 | Working Capital/Sales(x) | -5.37 | -6.24 | -5.32 | -18.14 | -31.03 | Efficiency Ratios | | | | | | Fixed Capital/Sales(x) | 1.23 | 1.13 | 1.06 | 0.61 | 0.37 | Receivable days | 12.79 | 15.83 | 20.30 | 15.98 | 16.86 | Inventory Days | 7.99 | 9.93 | 17.22 | 15.01 | 14.84 | Payable days | 320.55 | 347.24 | 351.93 | 238.56 | 312.99 | Valuation Parameters | | | | | | PER(x) | 11.65 | 14.26 | 0.00 | 6.56 | 14.33 | PCE(x) | 7.53 | 7.72 | 8.33 | 2.57 | 7.48 | Price/Book(x) | 3.80 | 4.39 | 2.69 | 1.60 | 3.75 | Yield(%) | 0.33 | 0.41 | 0.00 | 0.00 | 0.41 | EV/Net Sales(x) | 1.66 | 1.72 | 1.05 | 0.57 | 1.12 | EV/Core EBITDA(x) | 5.74 | 5.79 | 4.61 | 2.02 | 5.94 | EV/EBIT(x) | 7.76 | 8.77 | 11.55 | 3.52 | 9.01 | EV/CE(x) | 1.06 | 1.04 | 0.88 | 0.60 | 1.58 | M Cap / Sales | 1.61 | 1.71 | 1.05 | 0.51 | 1.00 | Growth Ratio | | | | | | Net Sales Growth(%) | 33.14 | 43.92 | -20.54 | 3.47 | 10.91 | Core EBITDA Growth(%) | 29.56 | 88.44 | -36.12 | 55.74 | 20.36 | EBIT Growth(%) | 45.34 | 211.36 | -55.51 | 35.59 | 25.49 | PAT Growth(%) | 53.20 | 1,775.24 | -110.51 | 14.84 | 75.87 | EPS Growth(%) | 53.20 | 1,775.24 | -110.51 | 14.84 | 75.87 | Financial Stability Ratios | | | | | | Total Debt/Equity(x) | 0.39 | 0.41 | 0.40 | 0.31 | 0.52 | Current Ratio(x) | 0.48 | 0.61 | 0.63 | 0.75 | 0.84 | Quick Ratio(x) | 0.42 | 0.54 | 0.55 | 0.55 | 0.66 | Interest Cover(x) | 7.14 | 5.48 | 1.82 | 3.32 | 5.82 | Total Debt/Mcap(x) | 0.10 | 0.09 | 0.15 | 0.20 | 0.14 |
|
|
|
|
|
|